Literature DB >> 8098295

A randomized trial of penicillin and streptomycin in the prevention of post-partum infection in Uganda.

A Kampikaho1, L M Irwig.   

Abstract

We report findings of a randomized trial of penicillin and streptomycin to prevent post-partum infection conducted on 737 women who delivered consecutively at Kawempe Maternity Centre (KMC) in Kampala from 1st October, 1989 to 31st May, 1990. The objectives were: (i) to identify clinical post-partum infection using at least two of its symptoms and signs (fever, lower abdominal pain, lower abdominal tenderness, vaginal discharge); (ii) to identify the causes of post-partum infection using laboratory methods; and (iii) evaluate the effectiveness of prophylactic fortified procaine penicillin (PPF) and streptomycin on post-partum infection. Clinical infection occurred in 36.4% of the group not given antibiotics, 23.3% in the PPF group and 20.3% in the streptomycin group. Laboratory-confirmed infection occurred in 15.5% of the group not given antibiotics, 9.2% in the PPF group and 8.4% in the streptomycin group. However, severe laboratory-confirmed infection (severe clinical infection plus positive laboratory findings) occurred in 4.9% of the group not given antibiotics, 6.1% in the PPF group and 6.6% in the streptomycin group. In general, the organisms isolated included enterobacteria (35.9%), yeast and protozoa (31.6%), staphylococci (23.9%), streptococci (69%) and Neisseria (1.7%). The advantage of PPF and streptomycin was evident in most subgroups defined by clinical characteristics or laboratory findings. In view of the findings in this study, we believe that prophylactic antibiotics given in labor may have a role to play at reducing the incidence of post-partum infection. However, as the cost of antibiotics in developing countries is significant, the development of resistant organisms due to indiscriminate antibiotic use is also a concern and health resources are best used when targeted at specific populations, we feel that antibiotic prophylaxis should not be used routinely and that a more realistic view can be obtained by studying high-risk groups of women with more severe infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098295     DOI: 10.1016/0020-7292(93)90153-n

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  2 in total

Review 1.  Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: a systematic review.

Authors:  Farah Seedat; Chris Stinton; Jacoby Patterson; Julia Geppert; Bee Tan; Esther R Robinson; Noel Denis McCarthy; Olalekan A Uthman; Karoline Freeman; Samantha Ann Johnson; Hannah Fraser; Colin Stewart Brown; Aileen Clarke; Sian Taylor-Phillips
Journal:  BMC Pregnancy Childbirth       Date:  2017-07-26       Impact factor: 3.007

Review 2.  Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity.

Authors:  Mercedes Bonet; Erika Ota; Chioma E Chibueze; Olufemi T Oladapo
Journal:  Cochrane Database Syst Rev       Date:  2017-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.